title: Strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response.
authors.affiliation: University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
authors.forename: Onno W
authors.initials: OW
authors.lastname: Akkerman
authors.forename: Richard
authors.initials: R
authors.lastname: van Altena
authors.forename: Mathieu S
authors.initials: MS
authors.lastname: Bolhuis
authors.forename: Tjip S
authors.initials: TS
authors.lastname: van der Werf
authors.forename: Jan-Willem
authors.initials: JW
authors.lastname: Alffenaar
mesh_terms: D000995:Antitubercular Agents / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000493:pharmacokinetics*; D008297:Male; D011718:Pyrazinamide / Q000493:pharmacokinetics*; D012293:Rifampin / Q000493:pharmacokinetics*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin